These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 19923446)

  • 1. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Batf3-independent langerin- CX3CR1- CD8α+ splenic DCs represent a precursor for classical cross-presenting CD8α+ DCs.
    Petersen TR; Knight DA; Tang CW; Osmond TL; Hermans IF
    J Leukoc Biol; 2014 Dec; 96(6):1001-10. PubMed ID: 25170118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
    Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
    J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization.
    Elnekave M; Furmanov K; Nudel I; Arizon M; Clausen BE; Hovav AH
    J Immunol; 2010 Sep; 185(6):3463-71. PubMed ID: 20713888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.
    Osmond TL; Farrand KJ; Painter GF; Ruedl C; Petersen TR; Hermans IF
    J Immunol; 2015 Aug; 195(3):821-31. PubMed ID: 26078270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerin
    Prendergast KA; Daniels NJ; Petersen TR; Hermans IF; Kirman JR
    Front Immunol; 2018; 9():953. PubMed ID: 29867941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained in vivo depletion of splenic langerin(+) CD8α(+) dendritic cells is well-tolerated by lang-DTREGFP mice.
    Prendergast KA; Osmond TL; Ochiai S; Hermans IF; Kirman JR
    J Immunol Methods; 2014 Apr; 406():104-9. PubMed ID: 24556588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo.
    Idoyaga J; Cheong C; Suda K; Suda N; Kim JY; Lee H; Park CG; Steinman RM
    J Immunol; 2008 Mar; 180(6):3647-50. PubMed ID: 18322168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].
    de Brito C; Tomkowiak M; Ghittoni R; Caux C; Leverrier Y; Marvel J
    J Immunol; 2011 Feb; 186(3):1503-11. PubMed ID: 21187449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
    Petersen TR; Sika-Paotonu D; Knight DA; Simkins HM; Hermans IF
    PLoS One; 2011 Mar; 6(3):e17657. PubMed ID: 21483862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
    Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G
    J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
    Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
    J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
    van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
    J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
    Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
    J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation.
    Torti N; Walton SM; Murphy KM; Oxenius A
    Eur J Immunol; 2011 Sep; 41(9):2612-8. PubMed ID: 21604258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.